ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

被引：0
|
作者：
Gopaluni, Seerapani [1 ]
Goymer, Donna [2 ]
McClure, Mark [1 ]
Cahill, Hugh [2 ]
Broadhurst, Elizabeth [2 ]
Smith, Rona [1 ]
Jayne, David [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Cambridge Univ Hosp NHS Trust, Cambridge, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Randomised Open Label Comparative Clinical Trial on the Efficacy of Latanoprost and Timolol in Primary Open Angle Glaucoma
    Rao, Sharadashri
    Narayanan, P. V.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (01) : FC13 - FC15
  • [22] A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma
    Lewis, KD
    Thompson, JA
    Weber, JS
    Robinson, WA
    O'Day, S
    Lutzky, J
    Legha, SS
    Floret, S
    Ruvuna, F
    Gonzalez, R
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (01) : 89 - 94
  • [23] Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
    Cho, Jinhyun
    Kim, Hae Su
    Ku, Bo Mi
    Choi, Yoon-La
    Cristescu, Razvan
    Han, Joungho
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2162 - +
  • [24] Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial
    Naik, Haley B.
    Pichard, Dominique C.
    Schwartz, Daniella M.
    O'Brien, Michelle
    Masciocchi, Matthew
    Thompson, Julie
    Sen, H. Nida
    Steinberg, Seth M.
    Mitchell, Sandra A.
    de Jesus, Adriana A.
    McCalmont, Timothy H.
    Dey, Amit
    Rosenstein, Rachel K.
    Deng, Zuoming
    Goldbach-Mansky, Raphaela
    Mehta, Nehal N.
    Cowen, Edward W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1380 - 1383
  • [25] Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial
    Leroux, S.
    Jacqz-Aigrain, E.
    Elie, V.
    Legrand, F.
    Barin-Le Guellec, C.
    Aurich, B.
    Biran, V.
    Dusang, B.
    Goudjil, S.
    Coopman, S.
    Sanchez, R. Garcia
    Zhao, W.
    Manzoni, P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (09) : 1989 - 1999
  • [26] Open-label safety and efficacy pilot trial of intraperitoneal bevacizumab as palliative treatment in refractory malignant ascites
    El-Shami, K.
    Elsaid, A.
    El-Kerm, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
    Jones, Jeffrey A.
    Robak, Tadeusz
    Brown, Jennifer R.
    Awan, Farrukh T.
    Badoux, Xavier
    Coutre, Steven
    Loscertales, Javier
    Taylor, Kerry
    Vandenberghe, Elisabeth
    Wach, Malgorzata
    Wagner-Johnston, Nina
    Ysebaert, Loic
    Dreiling, Lyndah
    Dubowy, Ronald
    Xing, Guan
    Flinn, Ian W.
    Owen, Carolyn
    LANCET HAEMATOLOGY, 2017, 4 (03): : E114 - E126
  • [28] Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial
    Glauser, TA
    Pellock, JM
    Bebin, EM
    Fountain, NB
    Ritter, FJ
    Jensen, CM
    Shields, WD
    EPILEPSIA, 2002, 43 (05) : 518 - 524
  • [29] An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer
    Salzberg, Marc
    Rochlitz, Christoph
    Morant, Rudolf
    Thalmann, George
    Pedrazzini, Augusto
    Roggero, Enrico
    Schoeneberger, Astrid
    Knuth, Alexander
    Borner, Markus
    ONKOLOGIE, 2007, 30 (07): : 355 - 360
  • [30] Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
    Saida T.
    Kira J.-I.
    Kishida S.
    Yamamura T.
    Ohtsuka N.
    Ling Y.
    Torii S.
    Lucas N.
    Kuesters G.
    Steiner D.
    Tibung J.T.
    Neurology and Therapy, 2017, 6 (1) : 39 - 55
12345